E. N. Komedchikova

Genetically Encoded Self-Assembling Protein Nanoparticles for the Targeted Delivery In Vitro and In Vivo

E. N. Mochalova, O. Kolesnikova, V. Shipunova, 2023, Pharmaceutics.

Dual Regioselective Targeting the Same Receptor in Nanoparticle-Mediated Combination Immuno/Chemotherapy for Enhanced Image-Guided Cancer Treatment.

P. Prasad, A. Kabashin, A. Schulga, 2020, ACS nano.

Targeted Two-Step Delivery of Oncotheranostic Nano-PLGA for HER2-Positive Tumor Imaging and Therapy In Vivo: Improved Effectiveness Compared to One-Step Strategy

M. Nikitin, S. Deyev, V. Shipunova, 2023, Pharmaceutics.

Two-Step Targeted Drug Delivery via Proteinaceous Barnase-Barstar Interface and Doxorubicin-Loaded Nano-PLGA Outperforms One-Step Strategy for Targeted Delivery to HER2-Overexpressing Cells

A. S. Sogomonyan, M. Nikitin, S. Deyev, 2022, Pharmaceutics.

Two-Step Targeted Drug Delivery Via Proteinaceous Barnase-Barstar Interface and PLGA-Based Nano-Carrier

A. S. Sogomonyan, M. Nikitin, S. Deyev, 2021 .

Photothermal Therapy with HER2-Targeted Silver Nanoparticles Leading to Cancer Remission

M. M. Belova, M. Nikitin, S. Deyev, 2022, Pharmaceutics.

Targosomes: Anti-HER2 PLGA nanocarriers for bioimaging, chemotherapy and local photothermal treatment of tumors and remote metastases.

V. Shipunova, A. Syuy, E. N. Komedchikova, 2023, Journal of controlled release : official journal of the Controlled Release Society.

Surface Characteristics Affect the Properties of PLGA Nanoparticles as Photothermal Agents

M. Nikitin, O. Kolesnikova, V. Shipunova, 2023, Micromachines.

Lectin-Modified Magnetic Nano-PLGA for Photodynamic Therapy In Vivo

A. S. Sogomonyan, P. Nikitin, A. Zvyagin, 2022, Pharmaceutics.

Targeting Cancer Cell Tight Junctions Enhances PLGA-Based Photothermal Sensitizers’ Performance In Vitro and In Vivo

A. S. Sogomonyan, M. Nikitin, A. Zvyagin, 2021, Pharmaceutics.